Immunogenicity of 2 vs 3 doses of the quadrivalent human papillomavirus vaccine in girls aged 9 to 13 years after 60 months

Gina Ogilvie; Chantal Sauvageau; Marc DIonne; Shelly McNeil; Mel Krajden; Deborah Money; Simon Dobson

doi:10.1001/jama.2017.1840

Immunogenicity of 2 vs 3 doses of the quadrivalent human papillomavirus vaccine in girls aged 9 to 13 years after 60 months

Gina Ogilvie, Chantal Sauvageau, Marc DIonne, Shelly McNeil, Mel Krajden, Deborah Money, Simon Dobson

Decision Sciences

Research output: Contribution to journal › Letter › peer-review

16 Citations (Scopus)

Original language	English
Pages (from-to)	1687-1688
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	317
Issue number	16
DOIs	https://doi.org/10.1001/jama.2017.1840
Publication status	Published - Apr 25 2017

ASJC Scopus Subject Areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jama.2017.1840

Cite this

@article{49641b097973491caa79cbc1a55bba6a,

title = "Immunogenicity of 2 vs 3 doses of the quadrivalent human papillomavirus vaccine in girls aged 9 to 13 years after 60 months",

author = "Gina Ogilvie and Chantal Sauvageau and Marc DIonne and Shelly McNeil and Mel Krajden and Deborah Money and Simon Dobson",

year = "2017",

month = apr,

day = "25",

doi = "10.1001/jama.2017.1840",

language = "English",

volume = "317",

pages = "1687--1688",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "16",

}

TY - JOUR

T1 - Immunogenicity of 2 vs 3 doses of the quadrivalent human papillomavirus vaccine in girls aged 9 to 13 years after 60 months

AU - Ogilvie, Gina

AU - Sauvageau, Chantal

AU - DIonne, Marc

AU - McNeil, Shelly

AU - Krajden, Mel

AU - Money, Deborah

AU - Dobson, Simon

PY - 2017/4/25

Y1 - 2017/4/25

UR - http://www.scopus.com/inward/record.url?scp=85018250105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018250105&partnerID=8YFLogxK

U2 - 10.1001/jama.2017.1840

DO - 10.1001/jama.2017.1840

M3 - Letter

C2 - 28444267

AN - SCOPUS:85018250105

SN - 0098-7484

VL - 317

SP - 1687

EP - 1688

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 16

ER -

Immunogenicity of 2 vs 3 doses of the quadrivalent human papillomavirus vaccine in girls aged 9 to 13 years after 60 months

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Cite this